Tile

STAT Feeds

Exploring health and medicine for a decade.

337 feeds
Loading tags...
Tile
https://www.statnews.com/category/biotech/feed/ RSS

STAT Biotech news: Market-moving coverage of drug development

Biotech news: Inside the discoveries, personalities, and deals driving drug development in general and biomedical engineering in particular. Sign up for <a href="https://www.statnews.com/signup/readout/">The Readout</a> newsletter to get the latest on biotech delivered to your inbox.
Last seen 5 days ago 5 views
Tile
https://en.ilsole24ore.com/rss/casa--architettura.xml RSS

Il Sole 24 ORE - Real Estate

Il Sole 24 ORE - Real Estate
Last seen 2 weeks ago 2 views
Tile
https://en.ilsole24ore.com/rss/casa--protagonisti.xml RSS

Il Sole 24 ORE - Real Estate

Il Sole 24 ORE - Real Estate
Last seen 2 weeks ago
Tile
https://statusgator.com/blog/category/integrations/feed/ RSS

Integrations Archives | StatusGator

StatusGator Blog
Last seen 3 weeks ago 17 views
Tile
https://www.nist.gov/news-events/Mathematics%20and%20Statistics/rss.xml RSS

News and Events Feed by Topic

Last seen 1 month ago 7 views
Tile
https://blog.playstation.com/2025/05/05/playstation-store-april-2025s-top-downloads/feed/ RSS

Comments on: PlayStation Store: April 2025’s top downloads

Official PlayStation Blog for news and video updates on PlayStation, PS5, PS4, PS VR, PlayStation Plus and more.
Last seen 2 weeks ago 4 views
Tile
https://en.ilsole24ore.com/rss/casa--finanza-immobiliare.xml RSS

Il Sole 24 ORE - Real Estate

Il Sole 24 ORE - Real Estate
Last seen 2 weeks ago 7 views
Tile
https://statusgator.com/blog/category/early-warning-signals/feed/ RSS

Early Warning Signals Archives | StatusGator

StatusGator Blog
Last seen 3 weeks ago 31 views
Tile
https://claudestatus.com/rss.xml RSS

Claude Status

Real-time status updates for Claude services
Last seen 1 month ago 13 views
Tile
https://statusgator.com/blog/feed/ RSS

StatusGator

StatusGator Blog
Last seen 3 weeks ago 14 views
Tile
https://en.ilsole24ore.com/rss/casa--design.xml RSS

Il Sole 24 ORE - Real Estate

Il Sole 24 ORE - Real Estate
Last seen 2 weeks ago 2 views
Tile

View full article
Tile
Select a feed to view its content

Loading feed entries...

STAT+: Kailera’s own ‘triple-G’ drug also looks very powerful

STAT+: Kailera’s own ‘triple-G’ drug also looks very powerful

STAT+: Biotech execs, academic expert lament impact of FDA turnover on rare disease drug development

STAT+: Biotech execs, academic expert lament impact of FDA turnover on rare disease drug development

STAT+: Drugmakers guard IP more tightly amid China competition

STAT+: Drugmakers guard IP more tightly amid China competition

What do early data from Utah’s Doctronic AI pilot show?

What do early data from Utah’s Doctronic AI pilot show?

STAT+: Five biotech news updates to stay on top of today

STAT+: Five biotech news updates to stay on top of today

STAT+: An AI biotech CEO sets the record straight on AI drug development hype

STAT+: An AI biotech CEO sets the record straight on AI drug development hype

STAT+: How Kyle Diamantas defied expectations as he rose to lead the FDA

STAT+: How Kyle Diamantas defied expectations as he rose to lead the FDA

STAT+: Marc Tessier-Lavigne addresses new book’s allegations about his conduct in Stanford misconduct case

STAT+: Marc Tessier-Lavigne addresses new book’s allegations about his conduct in Stanford misconduct case

STAT+: A new ranking of pharma companies by R&D performance

STAT+: A new ranking of pharma companies by R&D performance

STAT+: Biotech veteran Jeremy Levin on why the industry’s future is secure, but American leadership is at risk

STAT+: Biotech veteran Jeremy Levin on why the industry’s future is secure, but American leadership is at risk

STAT+: Ahead of ASCO, all eyes on pancreatic cancer

STAT+: Ahead of ASCO, all eyes on pancreatic cancer

STAT+: An ASCO preview: What to watch for at cancer research’s big meeting

STAT+: An ASCO preview: What to watch for at cancer research’s big meeting

STAT+: Closely watched experimental Parkinson’s drug fails key clinical trial

STAT+: Closely watched experimental Parkinson’s drug fails key clinical trial

STAT+: Merck-Kelun lung cancer drug cut risk of tumor progression by 65%, ASCO abstract shows

STAT+: Merck-Kelun lung cancer drug cut risk of tumor progression by 65%, ASCO abstract shows

STAT+: Immunovant shares surge on arthritis trial data

STAT+: Immunovant shares surge on arthritis trial data

STAT+: Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study

STAT+: Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study

STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer

STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer

STAT+: Allogene CEO David Chang stepping down

STAT+: Allogene CEO David Chang stepping down

STAT+: EU and US advisers split over AstraZeneca breast cancer drug

STAT+: EU and US advisers split over AstraZeneca breast cancer drug

STAT+: Longevity startup Retro Biosciences says latest fundraising values it at $1.8 billion

STAT+: Longevity startup Retro Biosciences says latest fundraising values it at $1.8 billion